Thrombocytosis, neutrophilia and anemia during interleukin-2 therapy.
Rossini
F
F
Brivio
F
F
Mingozzi
S
S
Lissoni
P
P
Pioltelli
P
P
D002292:Carcinoma, Renal Cell / Q000628:therapy; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000628:therapy; D007964:Leukocytosis / Q000139:chemically induced*; D008875:Middle Aged; D009504:Neutrophils; D013922:Thrombocytosis / Q000139:chemically induced*
D007155:Immunologic Factors; D007376:Interleukin-2